Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.
Thompson RM, Dytfeld D, Reyes L, Robinson RM, Smith B, Manevich Y, Jakubowiak A, Komarnicki M, Przybylowicz-Chalecka A, Szczepaniak T, Mitra AK, Van Ness BG, Luczak M, Dolloff NG.
Thompson RM, et al. Among authors: mitra ak.
Oncotarget. 2017 May 30;8(22):35863-35876. doi: 10.18632/oncotarget.16262.
Oncotarget. 2017.
PMID: 28415782
Free PMC article.